Streetbeat News

KNW

Know Labs, Inc.

https://www.knowlabs.co

Industry

Hardware, Equipment & Parts

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Open

0.22

Mkt cap

26M

Volume

78K

High

0.24

P/E Ratio

-1.13

52-wk high

0.94

Low

0.22

Div yield

N/A

52-wk low

0.18

Know Labs will present results from its clinical study at the 2024 American Association of Clinical Endocrinology Annual Meeting, showcasing the accuracy and medical application of its proprietary sensor.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 1:16 pm

Benchmark analyst Bruce Jackson initiates coverage on Know Labs (AMEX:KNW) with a Speculative Buy rating and a price target of $1.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:03 pm

NetApp, Inc. (NASDAQ:NTAP) shares surged by approximately 17% in pre-market trading following the announcement of better-than-expected third-quarter financial results and positive guidance. The company reported adjusted earnings of $1.94 per share, surpassing the market estimates of $1.69 per share, with quarterly sales of $1.610 billion against expectations of $1.591 billion. Other stocks also showed significant movement in pre-market trading, with notable gainers including Nxu, Inc., Minim, Inc., and Dell Technologies Inc., among others. Conversely, several companies experienced declines, such as GigCapital5, Inc., Fisker Inc., and Sidus Space, Inc.

Portfolio Pulse from Avi Kapoor

March 01, 2024 | 1:31 pm

Know Labs, Inc. (NYSE:KNW) has secured a funding agreement with Lind Global Fund II LP for up to $12 million to accelerate its non-invasive medical diagnostic technology development. The initial $4 million funding is through convertible secured notes, with provisions for conversion into shares at a premium and issuance of a warrant for purchasing additional shares. This investment aims to support Know Labs' efforts in hardware development, clinical research, algorithm development, and intellectual property expansion, particularly for its wearable continuous glucose monitor pending FDA clearance.

Portfolio Pulse from Happy Mohamed

February 29, 2024 | 9:42 pm

Know Labs, Inc. (NYSE:KNW) announced the KnowU, a wearable non-invasive continuous glucose monitor (CGM), incorporating a proprietary sensor intended for FDA submission. The KnowU, smaller and lighter than its prototype, features on-board computing, built-in machine learning, and aims to enhance diabetes management by being durable, eliminating disposables, and offering easy connectivity with a mobile app. Know Labs plans to use the KnowU for accelerated data collection in FDA clinical trials, targeting a diverse range of glycemic levels and populations. The company, holding over 270 patents, aims to make diabetes care more accessible and affordable.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 2:02 pm

Know Labs reported a Q1 EPS loss of $(0.04), marking a 50% improvement from the $(0.08) per share loss reported in the same period last year.

Portfolio Pulse from Happy Mohamed

February 14, 2024 | 10:04 pm

Earnings reports for various companies are scheduled for February 14, 2024. The report includes projections for earnings per share and revenue for a wide range of companies across different sectors, including technology, healthcare, industrial, consumer goods, and financial services. Some companies are expected to report losses, while others anticipate profits.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:48 am

RayzeBio, Inc. (RYZB) shares surged 100% after announcing its acquisition by Bristol Myers Squibb for $62.50 per share in cash, valuing the deal at $4.1 billion. Other stocks also moved significantly in Tuesday's mid-day session, with ARB IOT Group Limited (ARBB) and IMAC Holdings, Inc. (BACK) among the top gainers, while PARTS iD, Inc. (ID) and Milestone Pharmaceuticals Inc. (MIST) were among the top losers.

Portfolio Pulse from Avi Kapoor

December 26, 2023 | 6:48 pm

Know Labs shares have declined following the announcement of an $18 million mixed shelf offering. This type of offering allows the company to sell various types of securities over time, which could dilute current shareholders' equity.

Portfolio Pulse from Benzinga Newsdesk

December 26, 2023 | 5:46 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. RayzeBio (RYZB) saw a 100.8% increase to $61.4 with a market cap of $3.6 billion. IMAC Hldgs (BACK) rose 74.02% to $4.21, and Gracell Biotechnologies (GRCL) went up by 59.93% to $9.9. Conversely, Milestone Pharmaceuticals (MIST) dropped 32.3% to $1.95, ENDRA Life Sciences (NDRA) fell 22.01% to $1.95, and Jin Medical International (ZJYL) declined by 18.51% to $111.67.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.